This is particularly evident in malignancies such as hepatocellular carcinoma, glioblastoma, and breast cancer, where STAT3 contributes to the self-renewal, survival, and chemoresistance of tumor-initiating cell populations under oxidative conditions [123,124,125]. The gene discussed is STAT3; the disease is neoplasm.